The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Modelling and targeting mechanical forces in organ fibrosis
Open accessAbstract
Few efficacious therapies exist for the treatment of fibrotic diseases, such as skin scarring, liver cirrhosis and pulmonary fibrosis, which is related to our limited understanding of the fundamental causes and mechanisms of fibrosis. Mechanical forces from cell-matrix interactions, cell-cell contact, fluid flow and other physical stimuli may play a central role in the initiation and propagation of fibrosis. In this Review, we highlight the mechanotransduction mechanisms by which various sources of physical force drive fibrotic disease processes, with an emphasis on central pathways that may be therapeutically targeted to prevent and reverse fibrosis. We then discuss engineered models of mechanotransduction in fibrosis, as well as molecular and biomaterials-based therapeutic approaches for limiting fibrosis and promoting regenerative healing phenotypes in various organs. Finally, we discuss challenges within fibrosis research that remain to be addressed and that may greatly benefit from next-generation bioengineered model systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A seminal study demonstrated that Cadherin-11 facilitates robust adhesion between M2-like macrophages and myofibroblasts, creating a niche enriched with active TGF-b (3, 57, 63, 64).”
From The mechanotransduction-immune axis in organ fibrosis: dual regulatory mechanisms and translational therapeutic perspectives (2025) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–226 of 226
Focusing on Mechanoregulation Axis in Fibrosis: Sensing, Transduction and Effecting
Wen, D., Gao, Y., Ho, C., Li, Y., Zhang, Y., Lyu, G., Hu, D., Li, Q., & Zhang, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.804680 · Cited by 25
Watanabe, Y., Tamura, M., Osajima, A., Anai, H., Kabashima, N., Serino, R., & Nakashima, Y. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00122.x · Cited by 25
A2aR inhibits fibrosis and the EMT process in silicosis by regulating Wnt/β-catenin pathway
Tian, Y., Xia, J., Yang, G., Li, C., Qi, Y., Dai, K., Wu, C., Guo, Y., Yao, W., & Hao, C. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114410 · Cited by 25
Finch, R., Sostelly, A., Sue-Ling, K., Bläuer, A., Duchâteau-Nguyen, G., Ukarma, L., Petry, C., Ravva, P., Villiger, P. M., & JUNKER, U. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-eular.3028 · Cited by 24
Guo, J. L., Díaz-Gómez, L. A., Xie, V. Y., Bittner, S. M., Jiang, E. Y., Wang, B., & Mikos, A. G. (2021) · Bioprinting · doi:10.1016/j.bprint.2021.e00136 · Cited by 24
Increased Primary Cilia in Idiopathic Pulmonary Fibrosis.
Lee, J., Oh, D. H., Park, K. C., Choi, J. E., Kwon, J. B., Lee, J.-H., Park, K., & Sul, H. J. (2018) · PubMed Central · doi:10.14348/molcells.2018.2307 · Cited by 24
Tanaka, R., Umemura, M., Narikawa, M., Fujita, T., Yokoyama, U., Ishigami, T., Kimura, K., Tamura, K., & Ishikawa, Y. (2018) · Physiological Reports · doi:10.14814/phy2.13687 · Cited by 23
Bioprinted Hydrogels for Fibrosis and Wound Healing: Treatment and Modeling
Guo, J. L., & Longaker, M. T. (2022) · Gels · doi:10.3390/gels9010019 · Cited by 23
Self-citationRenal tubular fluid shear stress promotes endothelial cell activation
Miravète, M., Klein, J., Besse‐Patin, A., Gonzalez, J., Pécher, C., Bascands, J., Mercier‐Bonin, M., Schanstra, J. P., & Buffin‐Meyer, B. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.105 · Cited by 22
Cadherin-11 and cardiac fibrosis: A common target for a common pathology
Riley, L. A., & Merryman, W. D. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109876 · Cited by 21
Mucins and CFTR: Their Close Relationship
Okuda, K., Shaffer, K. M., & Ehré, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810232 · Cited by 21
Xu, W., Kong, B., Xie, H.-T., Zhang, J., Liu, W., Liu, S., Zhang, Y., Yang, F., Xiao, J., Mi, S., et al. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2022.108936 · Cited by 20
Ion channels as a therapeutic target for renal fibrosis
Yan, P., Ke, B., & Fang, X. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1019028 · Cited by 19
Suppression of myeloid YAP antagonizes adverse cardiac remodeling during pressure overload stress
Francisco, J. J., Guan, J., Zhang, Y., Nakada, Y., Mareedu, S., Sung, E., Hu, C. J., Oka, S., Zhai, P., Sadoshima, J., et al. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.05.004 · Cited by 18
Fibromine is a multi-omics database and mining tool for target discovery in pulmonary fibrosis
Fanidis, D., Moulos, P., & Aidinis, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-01069-w · Cited by 17
Stiffness of the Extracellular Matrix: A Regulator of Prostaglandins in Pulmonary Fibrosis?
Jandl, K., & Kwapiszewska, G. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0398ed · Cited by 15
Lin, Y., Wang, J.-C., Wu, M.-S., Lin, Y., Chen, C.-R., Chen, C.-Y., Chen, K., & Peng, C.-C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124359 · Cited by 14
Imaging viscosity of intragranular mucin matrix in cystic fibrosis cells
Requena, S., Ponomarchuk, O., Castillo, M., Rebik, J., Brochiero, E., Borejdo, J., Gryczyński, I., Dzyuba, S. V., Gryczynski, Z. K., Grygorczyk, R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17037-2 · Cited by 14
Advanced In Vitro Modeling to Study the Paradox of Mechanically Induced Cardiac Fibrosis
Gartner, T. C. L. B., Stein, J. M., Muylaert, D. E. P., Bouten, C. V. C., Doevendans, P. A., Khademhosseini, A., Suyker, W. J. L., Sluijter, J. P. G., & Hjortnaes, J. (2021) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2020.0298 · Cited by 12
Fan, D., Ying, Z., Yang, Y., Qian, Q., Li, Y., Wang, P., An, X., & Yan, M. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116774 · Cited by 11
Nabai, L., Ghahary, A., & Jackson, J. K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081546 · Cited by 10
Ba, Y.-D., Sun, J.-H., & Xx, Z. (2020) · PubMed · doi:10.26355/eurrev_202010_23439 · Cited by 10
Sakamoto, N., Ogawa, M., Sadamoto, K., Takeuchi, M., & Kataoka, N. (2017) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-017-0487-6 · Cited by 9
Repurposing DPP4 Inhibition to Improve Hair Follicle Activation and Regeneration
Helm, M., Schmidt, M., DUCA, E. D., Liu, Y., Mortensen, L. S., Loui, J., Zheng, Y., Binder, H., Guttman‐Yassky, E., Cotsarelis, G., et al. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.04.027 · Cited by 5
Temporal progression of mediastinal lymphadenopathy in idiopathic pulmonary fibrosis
Wallis, T., Gudmundsson, E., Pontoppidan, K., Moğulkoç, N., Savaş, R., Unat, Ö. S., Vedwan, K., Battison, S., Thompson, F., Brereton, C. J., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.00024-2022 · Cited by 4
Najarasl, M., Bahadoran, H., Asadi, M.-H., Saheli, M., Asghari, M. H., Sodeifi, N., Ashtiani, M. K., Vosough, M., Baharvand, H., & Piryaei, A. (2022) · EXCLI journal · doi:10.17179/excli2022-4761 · Cited by 3
Research works printed but not linked: 2
- Kim, K. K. et al. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J. Clin. Invest. 119, 213–224 (2009).
- Wilder, J. & Patel, K. The clinical utility of FibroScan((R)) as a noninvasive diagnostic test for liver disease. Med. Devices 7, 107–114, (2014).
Cited by
Sorted by citations
de la Lastra, J. M. P., Wardell, S. J. T., Pal, T., de la Fuente‐Núñez, C., & Pletzer, D. (2024) · Journal of Medical Systems · doi:10.1007/s10916-024-02089-5 · Cited by 92
The mechanobiology of fibroblast activation in disease
Chang, Y., Lee, J. W. N., & Holle, A. W. (2025) · APL Bioengineering · doi:10.1063/5.0272393 · Cited by 30
Mechanical Signaling: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets
Long, Y., Wang, P., Lei, J., Su, B., Wei, Q., & Liu, X. (2025) · MedComm · doi:10.1002/mco2.70523 · Cited by 27
Advanced 3D scaffolds for corneal stroma regeneration: a preclinical progress
Salehi, A. O. M., Soleimani, M., Rios, K. S. C., Ortega-Lara, W. D. L., & Mamidi, N. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00090d · Cited by 22
Metadata
- Authors
- Mascharak, S., L. Guo, J., Griffin, M., E. Berry, C., C. Wan, D., & T. Longaker, M.
- Affiliations
- Stanford Medicine (US)
- Venue
- Nature Reviews Bioengineering
- Published
- 2024-01-18
- Volume
- 2
- Issue
- 4
- Pages
- 305-323
- ISSN
- 2731-6092 (ISSN-L)
- PMC
- PMC11567675
- OpenAlex
- W4390964997
- Cited by
- 59
- References
- 226
- Citations by year
- 2026: 33 · 2025: 21 · 2024: 5
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Reviews Bioengineering (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (F32HL167318)
- National Institute of General Medical Sciences (R01GM136659)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR081343)
- National Institute of Dental and Craniofacial Research (R01DE027346, U24DE029463, R01DE032677)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- organ fibrosis, mechanotransduction, mechanical forces, cell-matrix interactions, cell-cell contact, fluid flow, pulmonary fibrosis, liver cirrhosis, scar tissue
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
